Oversonic’s Robee set to revolutionize European health care
News November 04, 2025

Oversonic’s Robee set to revolutionize European health care

Oversonic Robotics Srl believes that its humanoid robot Robee could transform health care in Europe as it helps address the challenges of an ageing population, rising chronic conditions and the shortage of health care workers. Robee has already received CE mark certification as a class I medical device, and plans are underway to achieve class II certification next year as the company looks to make a significant social impact with its humanoid robot.

Oversonic Robotics Srl is poised to shake up the European healthcare landscape with its groundbreaking humanoid robot, Robee. The Italian company envisions Robee as a vital tool in tackling some of the most pressing challenges facing healthcare systems across the continent: an aging population, the increasing prevalence of chronic diseases, and a critical shortage of healthcare professionals.

Robee is designed to assist healthcare workers in a variety of tasks, freeing them up to focus on more complex and critical patient care. While the specific functionalities remain under wraps, Oversonic hints at Robee’s ability to perform routine tasks, provide companionship to patients, and assist with mobility. This automation of less demanding duties could significantly alleviate the workload of nurses, doctors, and other caregivers, potentially reducing burnout and improving overall patient care quality.

The company has already achieved a significant milestone, securing CE mark certification for Robee as a Class I medical device. This certification signifies that Robee meets essential safety and performance requirements under European Union regulations. This initial certification allows Oversonic to begin deploying Robee in certain healthcare settings for specific, low-risk applications.

Looking ahead, Oversonic has ambitious plans to further expand Robee's capabilities and applications. The company is actively working towards achieving Class II certification next year. This higher-level certification would open the door for Robee to perform more complex tasks and interact more directly with patients, potentially including assistance with medication administration or monitoring vital signs.

Oversonic emphasizes its commitment to making a positive social impact with Robee. They believe that the robot has the potential to not only improve the efficiency of healthcare systems but also enhance the lives of patients, particularly the elderly and those living with chronic conditions. As Europe grapples with the increasing demands on its healthcare infrastructure, Robee represents a promising step towards a more sustainable and patient-centered future. The company's progress will be closely watched as it navigates the regulatory landscape and prepares for wider deployment of its innovative robot.
Category: Technology